{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:30:35Z","timestamp":1777995035023,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.leukres.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:46:33Z","timestamp":1503017193000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia"],"prefix":"10.1016","volume":"61","author":[{"given":"Giovanni","family":"Caocci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Arras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Abruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Mulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Trucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Littera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Carcassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"La Nasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.08.005_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","article-title":"HLA-G molecules: from maternal-fetal tolerance to tissue acceptance","volume":"81","author":"Carosella","year":"2003","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2014.00476","article-title":"Insights into HLA-G genetics provided by worldwide haplotype diversity","volume":"5","author":"Castelli","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/gene.2013.67","article-title":"Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity","volume":"15","author":"Sabbagh","year":"2014","journal-title":"Genes Immun."},{"key":"10.1016\/j.leukres.2017.08.005_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000362377","article-title":"HLA-G in testicular germ cell tumors","volume":"37","author":"Karagoz","year":"2014","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.leukres.2017.08.005_bib0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1399-0039.2011.01781.x","article-title":"HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma","volume":"78","author":"Lau","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.leukres.2017.08.005_bib0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/187153011794982059","article-title":"HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy","volume":"11","author":"Yan","year":"2011","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"20","key":"10.1016\/j.leukres.2017.08.005_bib0045","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1158\/1078-0432.CCR-05-0456","article-title":"Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"11","author":"Leleu","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.leukres.2017.08.005_bib0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2141.2007.06647.x","article-title":"Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders","volume":"138","author":"Sebti","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12032-013-0460-8","article-title":"HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker","volume":"30","author":"Alkhouly","year":"2013","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2017.08.005_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/gcc.22235","article-title":"Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma","volume":"54","author":"Bielska","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2017.08.005_bib0065","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2013.095281","article-title":"HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism","volume":"99","author":"Rizzo","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2017.08.005_bib0070","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.4081\/ejh.2016.2606","article-title":"HLA-G expression and role in advanced-stage classical Hodgkin lymphoma","volume":"60","author":"Caocci","year":"2016","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.leukres.2017.08.005_bib0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12032-015-0664-1","article-title":"The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation","volume":"32","author":"Biedro\u0144","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.transproceed.2012.05.073","article-title":"Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation","volume":"45","author":"Waterhouse","year":"2013","journal-title":"Transplant. Proc."},{"issue":"2","key":"10.1016\/j.leukres.2017.08.005_bib0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2141.2007.06779.x","article-title":"The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia","volume":"139","author":"La Nasa","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11899-013-0190-1","article-title":"Immunology and immunotherapy of chronic myeloid leukemia","volume":"9","author":"Ilander","year":"2014","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.leukres.2017.08.005_bib0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1399-0039.2009.01235.x","article-title":"Killer immunoglobulin-like receptors (KIR2DL2 and\/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukemia","volume":"73","author":"Middleton","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.leukres.2017.08.005_bib0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.exphem.2013.01.008","article-title":"Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients","volume":"41","author":"La Nasa","year":"2013","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/cncr.23238","article-title":"Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia","volume":"112","author":"Kantarjian","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2017.08.005_bib0110","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.humimm.2009.07.015","article-title":"Human leukocyte antigen-G polymorphism in relation to expression, function, and disease","volume":"70","author":"Larsen","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0115","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1182\/blood-2011-05-352393","article-title":"Soluble HLA-G dampens CD94\/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells","volume":"118","author":"Morandi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.08.005_bib0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/ehm.09.72","article-title":"HLA-G expression in hematologic malignancies","volume":"3","author":"Yan","year":"2010","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1365-2141.2000.02345.x","article-title":"Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia","volume":"111","author":"Mizuno","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0145-2126(02)00228-X","article-title":"Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients","volume":"27","author":"Pol\u00e1kov\u00e1","year":"2003","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.08.005_bib0135","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1582-4934.2008.00175.x","article-title":"Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia","volume":"12","author":"Yan","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.leukres.2017.08.005_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1034\/j.1399-0039.2001.057001015.x","article-title":"Association of soluble HLA-G plasma levels with HLA-G alleles","volume":"57","author":"Rebmann","year":"2001","journal-title":"Tissue Antigens."},{"key":"10.1016\/j.leukres.2017.08.005_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-016-0277-y","article-title":"Current status and perspectives in translational biomarker research for PD-1\/PD-L1 immune checkpoint blockade therapy","volume":"9","author":"Ma","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2017.08.005_bib0150","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617304861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T08:02:25Z","timestamp":1531296145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617304861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":30,"alternative-id":["S0145212617304861"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.08.005","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}